Domzalski David
Transaction: 05/29/2026
BUY
Change
+30,791
Price
$0.31
Filing
06/02/2026
Type
BUY
VYNE Therapeutics Inc.
VYNE • Biotechnology
$28.56
— 0.00 (0.00%)
Current price
EarningsLatest report: Jun 30, 2026
WEAK PROFILEWeakConfidence: 70%
Quantitative profile — not an investment recommendation.
Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Weak historical ratio profile. The current evidence does not support a favorable risk/reward view.
Market Cap
$1.22M
Growth
—
Cash Flow
0/5
Trend
Negative
Evidence
Manageable debt level · 0Healthy liquidity · 12.53Negative growth trendWeak profitability
Financial data as of: Jun 30, 2026, 12:00 AM UTCLast earnings update: Jun 30, 2026, 12:00 AM UTCLast profile update: Aug 14, 2026, 12:37 PM UTC
Company Snapshot
Key valuation, quality, financial strength, momentum and analyst data.
Price$28.56
Change0.00%
Shares Out42.77K
Market Cap$1.22M
Enterprise Value$1.19M
52W Range14.03 - 74.47
Beta2.01
P/E-0.03
P/S1.28
P/B43.99
P/FCF-0.07
EV/Sales1.25
Price$28.56
Change0.00%
Shares Out42.77K
Market Cap$1.22M
Enterprise Value$1.19M
52W Range14.03 - 74.47
Beta2.01
P/E-0.03
P/S1.28
P/B43.99
P/FCF-0.07
EV/Sales1.25
EV/EBITDA-0.03
EV/FCF-0.07
Dividend Yield0.00%
Gross Margin95.96%
Oper. Margin-52.19%
Profit Margin-46.46%
Debt/Eq0.00
Current Ratio12.53
Quick Ratio12.53
Target$5.75
Target Upside-79.87%
Target Median$5.75
Target Range5.75 - 5.75
Volume93.26K
Avg Volume25.24K
EPS Surprise0.10
Investment DNA
How strong this company looks for long-term investors
35
out of 100
Business Quality
Margins, moat, returns
22/100
Financial Strength
Debt, cash, stability
70/100
Growth Potential
Revenue and expansion
20/100
Price Attractiveness
Cheap or expensive today
58/100
Why this score▼
Manageable debt level · 0Healthy liquidity · 12.53Negative growth trendWeak profitability
Analyst view
Analyst sentiment and price target
Analyst sentiment
Based on 2 analyst votes · 2026-09-05
75/100
Bullish
Bullish
1
Hold
1
Bearish
0
Price Target
2026-08-14
Low
$5.75
Mean
$5.75
Median
$5.75
High
$5.75
Insider Transactions
Recent executive and insider activity
Domzalski David
Transaction: 03/31/2026
SELL
Change
-14,232
Price
$0.60
Filing
04/02/2026
Type
SELL
Harsch Mutya
Transaction: 03/31/2026
SELL
Change
-4,007
Price
$0.60
Filing
04/02/2026
Type
SELL
| Insider | Type | Change | Price | Transaction | Filing |
|---|---|---|---|---|---|
| Domzalski David | BUY | +30,791 | $0.31 | 05/29/2026 | 06/02/2026 |
| Domzalski David | SELL | -14,232 | $0.60 | 03/31/2026 | 04/02/2026 |
| Harsch Mutya | SELL | -4,007 | $0.60 | 03/31/2026 | 04/02/2026 |
| Stuart Iain | SELL | -2,876 | $0.60 | 03/31/2026 | 04/02/2026 |
| Zeronda Tyler | SELL | -4,007 | $0.60 | 03/31/2026 | 04/02/2026 |
| Harsch Mutya | SELL | -3,579 | $0.58 | 12/31/2025 | 01/05/2026 |
| Stuart Iain | SELL | -2,448 | $0.58 | 12/31/2025 | 01/05/2026 |
| Zeronda Tyler | SELL | -7,858 | $0.58 | 12/31/2025 | 01/05/2026 |
| Domzalski David | SELL | -12,684 | $0.58 | 12/31/2025 | 01/05/2026 |
| BARBARI SHARON | BUY | +20,000 | $0.38 | 12/12/2025 | 12/15/2025 |
| Basta Steven L | BUY | +20,000 | $0.38 | 12/12/2025 | 12/15/2025 |
| LEPORE PATRICK G | BUY | +20,000 | $0.38 | 12/12/2025 | 12/15/2025 |
| Little Elisabeth Sandoval | BUY | +20,000 | $0.38 | 12/12/2025 | 12/15/2025 |
| Domzalski David | SELL | -12,676 | $0.34 | 09/30/2025 | 10/02/2025 |
| Harsch Mutya | SELL | -3,581 | $0.34 | 09/30/2025 | 10/02/2025 |
| Stuart Iain | SELL | -2,453 | $0.34 | 09/30/2025 | 10/02/2025 |
| Zeronda Tyler | SELL | -3,420 | $0.34 | 09/30/2025 | 10/02/2025 |
| Domzalski David | SELL | -12,676 | $1.65 | 06/30/2025 | 07/02/2025 |
| Harsch Mutya | SELL | -3,581 | $1.65 | 06/30/2025 | 07/02/2025 |
| Stuart Iain | SELL | -2,453 | $1.65 | 06/30/2025 | 07/02/2025 |